Posts

Showing posts with the label bioreactors and fermenters mar

Bioreactors And Fermenters Market Report 2025, Share, Growth

Image
What Is the Predicted Market Size and CAGR of the Bioreactors And Fermenters Market by the End of the 2030? The bioreactors and fermenters market size has grown rapidly in recent years. It will grow from $4.69 billion in 2025 to $5.35 billion in 2026 at a compound annual growth rate (CAGR) of 14.2%. The growth in the historic period can be attributed to expansion of biopharmaceutical manufacturing capacity, increasing use of microbial fermentation processes, growth in academic and research bioprocess studies, rising demand for biologics production, improvements in stainless steel bioreactor design. The bioreactors and fermenters market size is expected to see rapid growth in the next few years. It will grow to $8.44 billion in 2030 at a compound annual growth rate (CAGR) of 12.1%. The growth in the forecast period can be attributed to increasing investments in biologics and biosimilars, rising adoption of continuous manufacturing, expansion of cell and gene therapy production, growing ...

Bioreactors And Fermenters Market is Projected to Grow Expeditiously: to Reach $7.67 Billion by 2029

Image
Focused on real-world business use, this report highlights what’s changing in the bioreactors and fermenters market and what companies should prepare for next. How Much Is The Bioreactors And Fermenters Market Worth? The bioreactors and fermenters market size has grown rapidly in recent years. It will grow from $4.12 billion in 2024 to $4.69 billion in 2025 at a compound annual growth rate (CAGR) of 13.9%. The growth in the historic period can be attributed to increasing demand for biopharmaceuticals, growing investments in research and development activities, expansion of the biotechnology industry, increasing focus on sustainable practices, and demand for personalized medicine. The bioreactors and fermenters market size is expected to see rapid growth in the next few years. It will grow to " $7.67 billion in 2029 at a compound annual growth rate (CAGR) of 13.1%. The growth in the forecast period can be attributed to emerging biopharmaceutical companies, demand for vaccine produc...